Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Clinical Investigation
Hemodynamic and Hormonal Effects of Beraprost Sodium, an Orally Active Prostacyclin Analogue, in Patients With Secondary Precapillary Pulmonary Hypertension
Fumiaki OnoNoritoshi NagayaShingo KyotaniHideo OyaNorifumi NakanishiKunio Miyatake
Author information
JOURNAL FREE ACCESS

2003 Volume 67 Issue 5 Pages 375-378

Details
Abstract

Earlier studies have shown that administration of beraprost sodium (BPS), an orally active prostacyclin analogue, improves hemodynamics in patients with primary pulmonary hypertension (PH), but it is not known whether BPS has beneficial effects in secondary precapillary PH. The present study investigated the hemodynamic and hormonal parameters of 18 patients with secondary precapillary PH (8 patients with chronic thromboembolic PH, 7 with collagen vascular disease, and 3 with residual PH after surgery for atrial septal defect). Hemodynamics were repeatedly measured by right heart catheterization. Treatment with BPS improved New York Heart Association (NYHA) functional class in 10 of the 18 patients and significantly decreased pulmonary vascular resistance by 17% (12.9±1.1 to 10.7±1.2 Wood units, p<0.01). Circulating brain natriuretic peptide and uric acid significantly decreased from 246±61 to 215±65 pg/ml and from 6.5±0.6 to 5.3±0.3 mg/dl, respectively. In summary, BPS therapy improved NYHA functional class, hemodynamics, and hormonal parameters in patients with secondary precapillary PH. Thus, oral administration of BPS may be a new therapeutic strategy for the treatment of secondary precapillary PH. (Circ J 2003; 67: 375 - 378)

Content from these authors
© 2003 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top